Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03912376 · ClinicalTrials.gov registry record
A Study of a Device Used to Take Pictures of Skin Blood Flow
A clinical trial of Basal Blood Flow, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT03912376 is a study of Basal Blood Flow that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03912376, a study of Basal Blood Flow, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is see fi the hyperspectral camera system (HCS) can measure skin blood flow (perfusion and oxygenation) in healthy people.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quest Hyperspectral Imaging System
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-04-05 |
| Est. Completion | 2024-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03912376
The ClinicalTrials.gov registry entry for NCT03912376 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Basal Blood Flow appearing as the primary indexed condition, and to 1 intervention - of which Quest Hyperspectral Imaging System is the first listed.
NCT03912376 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03912376 about?
NCT03912376 is a clinical study titled "A Study of a Device Used to Take Pictures of Skin Blood Flow". The purpose of this study is see fi the hyperspectral camera system (HCS) can measure skin blood flow (perfusion and oxygenation) in healthy people.
What is the current status of trial NCT03912376?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2019-04-05. Estimated completion is 2024-09-23.
What conditions does trial NCT03912376 study?
This clinical trial studies the following conditions: Basal Blood Flow.
What interventions are being tested in trial NCT03912376?
The interventions under investigation include: Quest Hyperspectral Imaging System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03912376?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03912376 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.